发明名称 SRM ASSAY FOR PD-L1
摘要 The current disclosure provides for specific peptides, and derived ionization characteristics of the peptides, from the PD-L1 protein that are particularly advantageous for quantifying the PD-L1 protein directly in biological samples that have been fixed in formalin by the method of Selected Reaction Monitoring (SRM) mass spectrometry, or what can also be termed as Multiple Reaction Monitoring (MRM) mass spectrometry. Such biological samples are chemically preserved and fixed wherein said biological sample is selected from tissues and cells treated with formaldehyde containing agents/fixatives including formalin-fixed tissue/cells, formalin-fixed/paraffin embedded (FFPE) tissue/cells, FFPE tissue blocks and cells from those blocks, and tissue culture cells that have been formalin fixed and/or paraffin embedded. PD-L1 peptides having modified or unmodified residues can be quantitated. An example of a modification of a PD-L1 fragment peptide is a phosphorylated tyrosine, threonine, serine, and/or other amino acid residues within the peptide sequence.
申请公布号 EP3092495(A2) 申请公布日期 2016.11.16
申请号 EP20150733236 申请日期 2015.01.06
申请人 EXPRESSION PATHOLOGY, INC. 发明人 KRIZMAN, DAVID, B.;HEMBROUGH, TODD;THYPARAMBIL, SHEENO;LIAO, WEI-LI;AN, EUNKYUNG
分类号 G01N33/68 主分类号 G01N33/68
代理机构 代理人
主权项
地址